NK cells: new insights on physiology and clinical implication in diseases;Les cellules natural killer : acquisitions récentes et implication en pathologie humaine

Revue de Medecine Interne

Volumn 27, Issue 6, 2006, Pages 465-472

  Schleinitz, N ^a   Hamidou, M ^b   Vely F ^a   Paul, P ^a   Figarella Branger, D ^c   Kaplanski, G ^a   Dignat George, F ^a   Vivier, E ^d   Harle J R ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔTEL DIEU   (France)

^c TIMONE HOSPITAL   (France)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

NK cells; NK receptors

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; RANTES; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN RECEPTOR;

ALLELE; ALLOIMMUNITY; AUTOIMMUNE DISEASE; B LYMPHOBLAST; CELL ACTIVATION; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELL FUNCTION; CLINICAL PRACTICE; CYTOKINE PRODUCTION; CYTOLOGY; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EVALUATION; FETUS WASTAGE; GENETIC POLYMORPHISM; GENOTYPE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INFECTION; INFERTILITY; INNATE IMMUNITY; KNOWLEDGE; LYMPHOCYTE FUNCTION; MENSTRUAL CYCLE; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; REGULATORY MECHANISM; SHORT SURVEY; T LYMPHOCYTE; TARGET CELL; TRANSPLANTATION; TUMOR; ANIMAL; ANIMAL MODEL; HUMAN; IMMUNOLOGY; NEOPLASM; REVIEW;

ANIMALS; CHEMOKINES; CYTOKINES; HUMANS; IMMUNOLOGIC SURVEILLANCE; INFECTION; KILLER CELLS, NATURAL; MODELS, ANIMAL; NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 33744915249     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.10.022     Document Type: Short Survey

References (58)

1. Cooper M.A., Fehniger T.A., and Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22 (2001) 633-640
2. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 15 101 (2003) 3052-3057
3. Zamai L., Ahmad M., Bennett I.M., Azzoni L., Alnemri E.S., and Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188 (1998) 2375-2380
4. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17 (1999) 189-220
5. Andoniou C.E., Scalzo A.A., van Dommelen S.L., Wallace M.E., Smyth M.J., and Degli-Esposti M.A. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol. Immunol. 42 (2005) 547-555
6. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A. NK cell and DC interactions. Trends Immunol. 25 (2004) 47-52
7. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2 (2002) 957-964
8. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11 (1990) 237-244
9. Long E.O., Barber D.F., Burshtyn D.N., Faure M., Peterson M., Rajagopalan S., et al. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev. 181 (2001) 223-233
10. Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., et al. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181 (2001) 203-214
11. Andre P., Biassoni R., Colonna M., Cosman D., Lanier L.L., Long E.O., et al. New nomenclature for MHC receptors. Nat. Immunol. 2 (2001) 661
12. Blery M., Olcese L., and Vivier E. Early signaling via inhibitory and activating NK receptors. Hum. Immunol. 6 (2000) 51-64
13. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19 (2001) 197-223
14. Long E.O., and Rajagopalan S. Stress signals activate natural killer cells. J. Exp. Med. 2 196 (2002) 1399-1402
15. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 (2001) 1055-1060
16. Arnon T.I., Achdout H., Lieberman N., Gazit R., Gonen-Gross T., Katz G., et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 15 103 (2004) 664-672
17. Vivier E., Nunes J.A., and Vely F. Natural killer cell signaling pathways. Science 26 306 (2004) 1517-1519
18. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 7 (1997) 753-763
19. Parham P. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol. Lett. 92 (2004) 11-13
20. Martin A.M., Kulski J.K., Gaudieri S., Witt C.S., Freitas E.M., Trowsdale J., et al. Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 335 (2004) 121-131
21. Yokoyama W.M., and Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3 (2003) 304-316
22. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7 (1997) 739-751
23. Pascal V., Schleinitz N., Brunet C., Ravet S., Bonnet E., Lafarge X., et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur. J. Immunol. 34 (2004) 2930-2940
24. Zambello R., Falco M., Della Chiesa M., Trentin L., Carollo D., Castriconi R., et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 102 (2003) 1797-1805
25. Chiesa S., Tomasello E., Vivier E., and Vely F. Coordination of activating and inhibitory signals in natural killer cells. Mol. Immunol. 42 (2005) 477-484
26. Arase H., and Lanier L.L. Specific recognition of virus-infected cells by paired NK receptors. Rev. Med. Virol. 14 (2004) 83-93
27. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320 (1989) 1731-1735
28. Nakajima H., Cella M., Bouchon A., Grierson H.L., Lewis J., Duckett C.S., et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30 (2000) 3309-3318
29. Aspalter R.M., Sewell W.A., Dolman K., Farrant J., and Webster A.D. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin. Exp. Immunol. 121 (2000) 506-514
30. De Vries E., Koene H.R., Vossen J.M., Gratama J.W., von dem Borne A.E., Waaijer J.L., et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood 15 88 (1996) 3022-3027
31. Gazit R., Garty B.Z., Monselise Y., Hoffer V., Finkelstein Y., Markel G., et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103 (2004) 1965-1966
32. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33 (2003) 2410-2418
33. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31 (2002) 429-434
34. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
35. Loughran Jr. T.P. Clonal diseases of large granular lymphocytes. Blood 82 (1993) 1-14
36. Semenzato G., Zambello R., Starkebaum G., Oshimi K., and Loughran Jr. T.P. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89 (1997) 256-260
37. Hamidou M., and Lamy T. Proliférations chroniques à grands lymphocytes granuleux. Aspects cliniques et pathogéniques. Rev. Med. Interne 22 (2001) 452-459
38. Waller E.K. Cellular immunotherapy and cancer. Semin. Oncol. 31 2 Suppl 4 (2004) 87-90
39. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
40. Velardi A., Ruggeri L., Moretta A., and Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 23 (2002) 438-444
41. Farag S.S., Fehniger T.A., Ruggeri L., Velardi A., and Caligiuri M.A. Natural killer cell receptors: new biology and insights into the graft-vs-leukemia effect. Blood 100 (2002) 1935-1947
42. Costello R.T., Sivori S., Marcenaro E., Lafage-Pochitaloff M., Mozziconacci M.J., Reviron D., et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99 (2002) 3661-3667
43. French A.R., and Yokoyama W.M. Natural killer cells and autoimmunity. Arthritis Res. Ther. 6 (2004) 8-14
44. Baxter A.G., and Smyth M.J. The role of NK cells in autoimmune disease. Auto-immunity 35 (2002) 1-14
45. Riccieri V., Spadaro A., Parisi G., Taccari E., Moretti T., Bernardini G., et al. Down-regulation of natural killer cells and of gamma-delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?. Lupus 9 (2000) 333-337
46. Erkeller-Yuksel F.M., Lydyard P.M., and Isenberg D.A. Lack of NK cells in lupus patients with renal involvement. Lupus 6 (1997) 708-712
47. Yabuhara A., Yang F.C., Nakazawa T., Iwasaki Y., Mori T., Koike K., et al. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J. Rheumatol. 23 (1996) 171-177
48. Markeljevic J., Marusic M., Uzarevic B., Petrovecki M., Cikes N., Babic-Naglic D., et al. Natural killer cell number and activity in remission phase of systemic connective tissue diseases. J. Clin. Lab. Immunol. 35 (1991) 133-138
49. Gonzalez-Amaro R., Alcocer-Varela J., and Alarcon-Segovia D. Natural killer cell activity in the systemic connective tissue diseases. J. Rheumatol. 15 (1988) 1223-1228
50. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., and Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J. Immunol. 173 (2004) 4273-4276
51. Martin M.P., Nelson G., Lee J.H., Pellett F., Gao X., Wade J., et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169 (2002) 2818-2822
52. Momot T., Koch S., Hunzelmann N., Krieg T., Ulbricht K., Schmidt R.E., et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 50 (2004) 1561-1565
53. Larroche C., and Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun. Rev. 3 (2004) 69-75
54. Moins-Teisserenc H.T., Gadola S.D., Cella M., Dunbar P.R., Exley A., Blake N., et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet 354 (1999) 1598-1603
55. Parham P. NK cells and trophoblasts: partners in pregnancy. J. Exp. Med. 200 (2004) 951-955
56. Dosiou C., and Giudice L.C. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr. Rev. 26 (2005) 44-62
57. Moffett A., Regan L., and Braude P. Natural killer cells, miscarriage, and infertility. BMJ 329 (2004) 1283-1285
58. Hiby S.E., Walker J.J., O'shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200 (2004) 957-965